A vaccine, funded by the Bill and Melinda Gates Foundation, designed to treat the disease caused by the coronavirus (COVID-19), has entered into the human stages of testing after the US Food and Drug Administration (FDA) approved their application to begin trials under the classification of an Investigational New Drug program following promising results achieved during animal testing.
Inovio Pharmaceuticals, the developers behind the INO-4800 DNA vaccine, began injecting volunteers with their first dose of the vaccine Monday - the second dose will be administered four weeks later. Inovio is expecting the initial data from the trials result by late summer.
